Member Info for Pike1975

Neil, my very best wishes to you and your wife. I wish her a full and speedy recovery.

Hi Cymru,

Yep, that was the convo Allan and I had at the 2019 AGM. I banged on that drum for months - haha

He knew…..and now we all know, it’s a very very special share.

Interview just out - Traders Cafe with Zak Mir: Alan Syms, CEO Cizzle Biotechnology

First 'big milestone' has been achieved with the announcement this week.

Still holding as I believe CIZ will do extremely well.

Great post Neil,

Echos my sentiments entirely.

I’ve said this before here and I’ll say it again...Allan told me personally at the 2019 AGM we were lucky to be involved in this.

I’m looking forward to seeing him again at the next AGM, which says a lot about my intentions here also.

Hi Dapr,

I don't think either myself or anyone else here would think you were being disrespectful, but I appreciate your words. I just try to look at the situation from a balanced perspective. Of course, we are all tired of waiting that's for sure, having funds locked in for so long. After all it has been 490 days in suspension.

Marko posted a link last week on FCA delays. Here's another one I grabbed from another bb recently that I found particularly interesting. Pointing to regulatory delays in the listing (authorisation) of companies, that could have had an impact on us.

https://citywire.co.uk/new-model-adviser/news/exclusive-fca-drafts-in-outsiders-to-tackle-authorisation-backlog/a1448884

That said, we are now in active discussions with the regulator and I hope its a case of they are now spelling out what needs to be done.

ATB

Dapr

Haven’t posted in a while, but just wanted to comment on your post re: is this still potentially relevant now to some time ago? In answer to that, I would say yes, if not more so..

We all know the target is an early cancer detection target co. Agreed? So what has changed? Definitely not a cure that’s for sure.

I would argue that the need is now greater for early cancer detection due to the operational standard targets that are being missed by the NHS due to COVID.

There were actually 4 million less diagnostic scans between April 2020 - Sept 2020 compared to the same period in 2019.

Experts including those from CRUK have recently said that the growing wait for diagnosis illustrates the clear need for access to new forms of early cancer screening methods.

With Grail’s recent trials announced by the NHS and Government Cancer Diagnosis targets, it is clear that rolling out high quality, fast diagnostic services require close and co-operative working with diagnostic industries.

Shows the potential ahead for early Cancer detection.

I agree with those who have posted earlier to give them a little more time, however I also agree with and share the frustrations, but things are now progressing better than you may think.

Hi Stimpy,

For balance you do make a reasonable point.

Neil has gained more traction/information in two days than most shareholders have since suspension in October 2019. I mean no disrespect to anyone here, but on the face of it, it does seem to be the case this week.

Whilst I am still on the fence regarding the various ‘proposed actions’ over the past 48 hours, I accept Neil has gone over and above for his fellow investors in the spirit of everyone’s best intentions.

However. Whatever Neil has been told is enough to still satisfy him of his investment decision and fair play to him, that’s the name of the game isn’t it?

But is that for him to know and for others to have picked the phone up to IFC/BOD and done the same?

Hi Neil, by the sounds and looks of it most here would want the AGM and right at the top of the agenda for shareholders I believe WOULD be re-electing the board?

I don’t feel any disgruntled shareholder would want less than that - To cast their vote against a BODs who have ultimately let them down.

The rethoric from our bb has been in the main the fault and inadequacies of the BOD, so why would anyone not want a meaningful vote on that? It’s a fair request.

I remember a similar situation arising just before the last AGM regarding Martin Lampshire. Everyone piled in with their votes against, only at the 11th hour to be swayed by our largest shareholder via a prominent voice on this bb, not to vote him out.

That issue was all about needing three directors - otherwise we were screwed. So, Martin survived, he got the vote (albeit he took a hit).

However, when it comes to like roobler says using this a metaphorical punch bag to make us feel better, ultimately it comes down to whether you want to risk putting well intentioned actions that could take out the RTO and your investment altogether. Most last time didn’t.

I hold 132million and I’m not happy at all with this situation. I share equally the pain and frustration as I have said before. I am not saying anyone is wrong here, tensions are running high. I just ask shareholders to think any action through before going to defcon1!

I have also received communication, it’s not dead, the regulatory issues are holding this back.

They are confident of a good outcome.

Posted for balance guys and with good intentions.

Ortus/Neil

Wise words Gents. No matter how many abusive posts are given on here, it certainly doesn't add any value to the bb, nor does it have any positive impact on the BOD or the proposed transaction.

We are all heavily invested here, both in time and money and its clear from the positive efforts some are going to, we are clearly not Ostriches either.

Respectfully, lets keep a civil tone guys, like Ortus says even if its just to benefit fellow posters..

Great post RMR- couldn't agree more.

I agree that time is limited for 2020 but not mathematically impossible.

In terms of your question relating to running out of cash, I would look at the 2019 accounts to make an informed opinion.

At the end of 2019 after expenses including 275K on ‘proposed transaction costs’, 90K+ remuneration plus other various costs they had 378K in the bank.

I was informed in June of 2020, the company had sufficient funds for its current needs and should the business require further funds it was likely that these would be raised at the time of re-listing.

Hope that helps.

Hi Rooblertwo

In short yes. The company would release information on ‘completion of the proposed transaction’ which would be subject to the company’s shareholders giving approval at a general meeting (to be convened in due course). As there would probably be a placing also, shareholders would be required to vote on this also.

As this point I would expect a prospectus and in order to convene a general meeting the company would be required to publish an admission document also for whichever ‘recognised exchange’ it is to list on.

The minimum full period of notice is 14 days, however AGM’s are longer I believe at 21 days.

I recall in our last corporate update, notice of an AGM would be given in due course, so expecting a vote? Yes most definitely.

All IMO.

Evening all,

I have received an update this evening.

The proposed transaction is progressing and the company is cautiously optimistic the transaction will be concluded in the coming weeks.

Tough as this is, it is out of the BODs control.

Hang in there, can’t be long now.

I agree RMR and thanks to you also Neil for sharing positivity this week. There are clearly those here who are still believers and those who are not.

Good posters try to find the positives among the negatives until they are told otherwise, or research and dig until they have concrete information to the contrary.

Negative posters are less likely to welcome new information if it contradicts what they now believe.

Positive or negative, we all do share the same common ground. We are all equally in the same boat whether we like it or not and starved of ‘official’ information. If there is one thing the BOD know it is this and I agree they do read this board. They need to act, that is not in question.

We should however welcome positivity from those who are STILL actively searching out the answers and have the decency to share their findings or opinions. Thank you to those who do and have this week.

Whatever the reason for these delays, which have been monumental to say the least, I stick to my previous mantra...we have not been told this is ‘officially’ over and until we do, we are still in the game.

Good luck to you all, we all do definitely deserve a new winter coat! (I liked that one Jace!)

It’s starting to get cold...

Thanks for sharing Tra1,

Very interesting read and shows what biotech companies in this field are worth.

I’m sure that most, if not all here, have done their research in to this field and discovered like myself, there are a good few companies out there developing/developed (some of whom are not listed btw), this early cancer detection tech. Some target specific types of cancer and others more ‘universal’. Some also on blood tests for tumours that are ‘as yet’ unavailable to the market.

We have all been informed this is a ‘new diagnostic test for the early detection of a cancer’ as per our recent corporate update (note how this has changed from April, when it was specific cancer detection). Maybe nothing.

This led me to research further and you’ll find some who are still ‘currently’ awaiting very recent ‘assay validation’, to provide an assurance of reliability during normal use – evidence that the method does what it is intended to do. Who would verify this? QCQ?

Whilst there have been a number of stinging attacks on our BOD lately (and I’m not defending them by the way), could this be our problem? Issues outside of BOU’s control as communicated so often by Tim at IFC? Perhaps. I know this has been mentioned by a previous poster.

What I am quite confident in is this.

Currently the testing and screening systems for cancer due to COVID are in no way going to return to pre COVID levels for some time to come. Thousands of cancer cases will be going undetected and undiagnosed each week. The NHS will have to adapt to cancer detection and diagnostic services to cope with COVID, not only in suspected cases but also in possible relapsed patients.

Fewer referrals to secondary care and an overall reduced burden on cancer services will push for expanded cancer screening services. Which is where ultimately these companies will come to the forefront in particular those offering easy annual non hospitalised screening.

IF and I say if (as I have absolutely no knowledge that this is coming back or not, although confident) and it’s something along the lines of what I have researched, then we could be at the start of something quite exciting.

Intended only to keep spirits up!

@Rooblertwo - I would imagine misinterpreted, or that he doesn’t want to comment on correspondence he has had directly with other shareholders perhaps? I can concur with those that have commented on or in part posted Tim’s replies of late. Yes, some are standard investor replies, however Tim has always been happy to answer more detailed questions, that fall within his allowed boundaries.

@JB - yes your correct that - As Bould is now a private company it has until 30 September to file its accounts for the period ended 31 December 2019. They may also tie this in with a corporate update (perhaps) if still nothing solid on the readmission progress. I believe the board owe us that at the very least.

Hi M.Aurelius

Merry Christmas to you too.

We chatted at the GM the three of us, wondered if your on Twitter mate? If so could you drop me a DM? My handle is Pike @toothypredator

Regards Pike

Yes, definitely attending...bit of a trek for me, but with lack of news, worth every mile!

Same here Jimmy. 30Mil dummy sell... Share Centre will take them all at 0.028